Translational Development Acquisition Corp. Ordinary Shares (TDAC) — Financial Flexibility Index

Latest as of September 2025: -0.19x

Translational Development Acquisition Corp. Ordinary Shares (TDAC) has a Financial Flexibility Index of -0.19x as of September 2025. Free cash flow of $-1.24 Million (operating CF $-1.24 Million minus capex $0.00) represents 0% of total liabilities ($6.46 Million). Check TDAC capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.

Financial Flexibility Index

-0.19x
Free Cash Flow / Total Liabilities

Free Cash Flow

$-1.24 Million
Operating CF − Capex

Total Liabilities

$6.46 Million
USD

Capital Expenditures

$0.00
USD

Translational Development Acquisition Corp. Ordinary Shares Financial Flexibility Index (2022–2024)

Historical Financial Flexibility Index trend for Translational Development Acquisition Corp. Ordinary Shares across 3 annual periods. For the full cash flow conversion analysis, see Translational Development Acquisition Co operating cash flow efficiency.

Annual Financial Flexibility Index for Translational Development Acquisition Corp. Ordinary Shares (2022–2024)

Year-by-year free cash flow to debt coverage for Translational Development Acquisition Corp. Ordinary Shares. Explore Translational Development Acquisition Co (TDAC) cash flow to debt to assess how comfortably operating cash covers total debt obligations.

Year Flexibility Index Free Cash Flow (USD) Operating CF Total Liabilities YoY Change
2024 -0.14x $-851.44K $-851.45K $6.25 Million ▼ -33948.2%
2023 0.00x $-204.00 $-204.00 $509.68K ▲ +99.8%
2022 -0.21x $-97.16K $-97.16K $459.34K
Financial Flexibility Index = (Operating CF − Capex) / Total Liabilities = Free Cash Flow / Total Liabilities